We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

159 hedge funds and large institutions have $53.6M invested in Definium Therapeutics in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 33 increasing their positions, 41 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more call options, than puts

Call options by funds: $4.31M | Put options by funds: $1.54M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.06% less ownership

Funds ownership: 0.82% → 0.76% (-0.06%)

10% less funds holding

Funds holding: 176 → 159 (-17)

20% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 41

26% less capital invested

Capital invested by funds: $72.4M → $53.6M (-$18.9M)

33% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 48

Holders
159
Holders Change
-17
Holders Change %
-9.66%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
33
Reduced
41
Closed
48
Calls
$4.31M
Puts
$1.54M
Net Calls
+$2.77M
Net Calls Change
-$81K

Top Buyers

1
State Street
State Street
Massachusetts
+$482K
2
MI
MMCAP International
Cayman Islands
+$278K
3
PCM
Penserra Capital Management
California
+$276K
4
AI
AdvisorShares Investments
Maryland
+$268K
5
Swiss National Bank
Swiss National Bank
Switzerland
+$206K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$740K
2
BlackRock
BlackRock
New York
-$730K
3
LPL Financial
LPL Financial
California
-$534K
4
Citadel Advisors
Citadel Advisors
Florida
-$533K
5
Two Sigma Investments
Two Sigma Investments
New York
-$516K
Name Holding Trade Value Shares
Change 		Change in
Stake
BAM
126
Baldrige Asset Management
Pennsylvania
$2K – – –
FRA
127
Front Row Advisors
California
$2K – – –
Rockefeller Capital Management
128
Rockefeller Capital Management
New York
$2K – – –
TFM
129
TFC Financial Management
Massachusetts
$2K – – –
US Bancorp
130
US Bancorp
Minnesota
$2K – – –
HWM
131
HighMark Wealth Management
Minnesota
$2K +$2.33K +134 New
RFWA
132
RPg Family Wealth Advisory
Massachusetts
$1.11K +$1.16K +67 New
ARMC
133
American Research & Management Company
Massachusetts
$1K – – –
AF
134
Arrow Financial
New York
$1K – – –
BCV
135
Banque Cantonale Vaudoise
Switzerland
$1K – – –
BC
136
Burleson & Co
California
$1K – – –
PK
137
Pflug Koory
Nebraska
$1K – – –
1832 Asset Management
138
1832 Asset Management
Ontario, Canada
$1K +$815 +47 New
AF
139
Allworth Financial
California
$1K +$1.16K +67 New
GWM
140
Geneos Wealth Management
Colorado
$1K +$1.16K +67 New
GEA
141
Glen Eagle Advisors
New Jersey
$481 +$503 +29 New
LTI
142
Laffer Tengler Investments
Tennessee
$111 – – –
AGM
143
Alpine Global Management
New York
$35 -$32.3K -1,862 -47%
LPL Financial
144
LPL Financial
California
– -$534K -25,814 Closed
D.E. Shaw & Co
145
D.E. Shaw & Co
New York
– -$231K -11,147 Closed
BC
146
BIT Capital
Germany
– -$193K -9,333 Closed
VOYA Investment Management
147
VOYA Investment Management
Georgia
– -$186K -8,971 Closed
E
148
Ergoteles
New York
– -$136K -6,589 Closed
GSC
149
Ground Swell Capital
South Carolina
– -$88K -4,247 Closed
SG Americas Securities
150
SG Americas Securities
New York
– -$86K -4,143 Closed
4 5
6
7 8

DFTX Hedge Fund Activity: Q1 2022 in Review

159 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q1 2022, worth a combined $53.6M — down 26% from $72.4M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of DFTX and 32 opened new positions — a net loss of 16 holders — while 41 trimmed existing stakes and 33 added.

The largest buyer was State Street, adding an estimated $482K. The largest seller was Millennium Management, cutting an estimated $740K.

  • 159 institutional investors held Definium Therapeutics (DFTX) as of Q1 2022, down from 176 in Q4 2021.
  • Funds reported $53.6M of Definium Therapeutics stock for Q1 2022, down 26% quarter-over-quarter.
  • 32 funds opened new Definium Therapeutics positions in Q1 2022 and 48 closed out, a net change of -16 holders.
  • The largest Definium Therapeutics buyer in Q1 2022 was State Street, an estimated $482K added.
  • The largest Definium Therapeutics seller in Q1 2022 was Millennium Management, an estimated $740K sold.

Based on aggregated 13F filings for Q1 2022.